El apixaban se asocia a un menor riesgo de sangrado que los antagonistas de la vitamina K

Cardenas, María Paula

El apixaban se asocia a un menor riesgo de sangrado que los antagonistas de la vitamina K / Apixaban is associated with a lower risk of bleeding than vitamin K antagonists

Cardenas, María Paula.

Cardenas, María Paula; Hospital Italiano de Buenos Aires. Servicio de Medicina Familiar y Comunitaria. Ciudad Autónoma de Buenos Aires. AR

Evid. actual. práct. ambul ; 21(2): 54-54, jul. 2018. tab.

Article in Spanish | LILACS | ID: biblio-1016287

Subject(s)

Humans; Male; Female; Adult; Middle Aged; Aged; Young Adult; Pyrazoles/adverse effects; Pyridones/adverse effects; Vitamin K/antagonists & inhibitors; Venous Thromboembolism/prevention & control; Hemorrhage/epidemiology; Anticoagulants/adverse effects; Pyrazoles/therapeutic use; Pyridones/therapeutic use; Randomized Controlled Trials as Topic; Global Health; Incidence; Risk Factors; Factor Xa Inhibitors/adverse effects; Factor Xa Inhibitors/therapeutic use; Hemorrhage/chemically induced; Anticoagulants/therapeutic use

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Pyrazoles / Pyridones / Vitamin K / Venous Thromboembolism / Hemorrhage / Anticoagulants Type of study: Controlled clinical trial / Etiology study / Incidence study / Prognostic study / Risk factors Limits: Adult / Aged / Female / Humans / Male Language: Spanish Journal: Evid. actual. práct. ambul Journal subject: Medicine / Delivery of Health Care Year: 2018 Type: Article Affiliation country: Argentina Institution/Affiliation country: Hospital Italiano de Buenos Aires/AR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google